Amsterdam/Utrecht, 4 April 2023 – Holland Capital sells its stake in Valori to Cerios.
Valori believes that embedding integral quality into IT systems is crucial to allow carefree innovation. The Quality Assurance and Test Consultants of Valori build towards the quality of IT systems in all stages of software development: Building IT Quality. Valori has been doing this for over 33 years with Quality Assurance advisory, expert services and proprietary technology solutions. The eventual goal is to bring software faster into production with better and more sustainable quality.
Growth through buy and build
Holland Capital has been an active shareholder of Valori since 2019. Over the last 4 years, they have supported the team of Jaap Merkus vigorously to improve the strategic positioning of the business and to further professionalise the organisation. The buy and build strategy of Valori led to 2 takeovers. As a result, Valori could offer its clients a uniquely integrated quality solution.
Ewout Prins, managing partner at Holland Capital: “We’re very proud that we had the opportunity to embark on this journey with Valori over the past 4 years where we could help realise their growth ambitions. The acquisition by Cerios will allow Valori to enter into a new chapter of its development.”
Jaap Merkus, CEO Valori: “Valori managed to realise a unique acceleration in achieving its ambitions thanks to the close collaboration with Holland Capital. Targeted acquisitions and solid entrepreneurship were at the centre of that. That is why we are ready for the next chapter where we will join Cerios, supported by Avedon. In collaboration with Cerios we will be able to realise the next stage of growth for our clients.”
Next stage of growth for Cerios
The new brand Cerios will bring together the flagship businesses Salves, De Agile Testers Quality Accelerators and Valori into one ‘House of Brands’. This will allow them to gain a leading position in the consolidating market of quality and software testing. Through this collaboration the companies create more opportunities for consultants and a broader offering for their clients while maintaining their proper identity and autonomy.
About Holland Capital
Over the past 40 years Holland Capital has responsibly and successfully invested in more than 160 SMEs. With a clear investment strategy Holland Capital is active in the attractive growth markets of healthcare, technology and food & agri. Holland Capital’s experienced, entrepreneurial and committed investment team aims to establish an open, sustainable and professional relationship with the companies it invests in with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs.
Sirius Medical raises €4.4M to launch Sirius Pintuition
Sirius Medical raises €4.4M to launch Sirius PintuitionAn innovative breast cancer localization technology Amsterdam, July 14th, 2020 – Investment company Holland Capital invests 4.4 million euros in Sirius Medical together with BOM Brabant Ventures and Curie Capital....
Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery
Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery Eindhoven, June 16, 2020 – Sirius Medical, a MedTech startup, announced that it has received CE mark approval for Sirius Pintuition. With its debut...
CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers
CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers Eindhoven, The Netherlands - 22 April 2020, - CytoSMART Technologies is to donate 100 mini live-cell imaging systems to researchers in high containment labs worldwide. Labs working to...
Yenlo Achieves Highest WSO2 Reseller Status as a Platinum VAR
Yenlo Achieves Highest WSO2 Reseller Status as a Platinum VAR Yenlo was named a WSO2 Platinum Value-Added Reseller in recognition of its success in growing global customer adoption and delivering best-in-class open source integration and API management solutions based...
Portfolio company Inno4Life sold to the Swiss company Dec Group
Portfolio company Inno4Life sold to the Swiss company Dec Group Amsterdam, April 16, 2020 - Earlier this month, Inno4Life, a manufacturer of machines for the pharmaceutical industry, was sold to the Swiss Dec Group. Inno4Life's management will remain actively involved...
Dutch Ministry of Health also opts for Evone® by Ventinova from Eindhoven
Dutch Ministry of Health also opts for Evone® by Ventinova from EindhovenResults of FCV®-equipped ventilation equipment appears promising Eindhoven, 2 April 2020 – Ventinova Medical, a company based in Eindhoven, received good news today; this concerns a substantial...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01